Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001127855-15-000017
Filing Date
2015-01-16
Accepted
2015-01-16 17:23:49
Documents
10
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 NAPRODIS 10K, 08.31.14 naprodis10k083114.htm 10-K 563637
2 NAPRODIS 10K, CERTIFICATION 302, CEO naprodisexh31_1.htm EX-31.1 9865
3 NAPRODIS 10K, CERTIFICATION 302, CFO naprodisexh31_2.htm EX-31.2 9435
4 NAPRODIS 10K, CERTIFICATION 906 naprodisexh32.htm EX-32 5321
  Complete submission text file 0001127855-15-000017.txt   3436900

Data Files

Seq Description Document Type Size
5 napr-20140831_cal.xml EX-101.CAL 23605
6 napr-20140831_def.xml EX-101.DEF 26384
7 napr-20140831.xml EX-101.INS 587039
8 napr-20140831_lab.xml EX-101.LAB 101764
9 napr-20140831_pre.xml EX-101.PRE 97183
10 napr-20140831.xsd EX-101.SCH 26484
Mailing Address 13250 GREGG STREET SUITE F POWAY CA 92064
Business Address 13250 GREGG STREET SUITE F POWAY CA 92064 (858) 486-8655
Naprodis, Inc. (Filer) CIK: 0001313938 (see all company filings)

EIN.: 330903494 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-122009 | Film No.: 15533431
SIC: 2834 Pharmaceutical Preparations